SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Preczewski Jennifer L (Last) (First) (Middle) C/O SCHLAGE LOCK COMPANY LLC 11819 N. PENNSYLVANIA STREET (Street) CARMEL IN 46032 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/18/2022	3. Issuer Name and Ticker or Trading Symbol Allegion plc [ ALLE ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) VP ? Chief HR Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	3,858(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	02/21/2029	Ordinary Shares	426	$88.08	D
Stock Option (Right to Buy)	(3)	02/20/2030	Ordinary Shares	1,074	$129.325	D
Stock Option (Right to Buy)	(4)	02/18/2031	Ordinary Shares	1,001	$109.14	D
Stock Option (Right to Buy)	(5)	02/17/2032	Ordinary Shares	1,312	$115.335	D

Explanation of Responses:

1. Includes: (i) 142 RSUs that vest on February 20, 2023; (ii) 306 RSUs that vest in equal annual installments on February 18, 2023 and February 18, 2024; (iii) 184 RSUs that vest in equal annual installments on February 18, 2023 and February 18, 2024; (iv) 651 RSUs that vest in equal annual installments on February 17, 2023, February 17, 2024 and February 17, 2025; (v) 1,735 RSUs that vest on February 17, 2024; and (vi) 840 shares that are directly owned.

2. A stock option that vested in equal annual installments on February 21, 2020, February 21, 2021 and February 21, 2022, and is exercisable.

3. A stock option that vests in equal annual installments on February 20, 2021, February 20, 2022 and February 20, 2023. To the extent the stock option has vested, it is exercisable.

4. A stock option that vests in equal annual installments on February 18, 2022, February 18, 2023 and February 18, 2024. To the extent the stock option has vested, it is exercisable.

5. A stock option that vests in equal annual installments on February 17, 2023, February 17, 2024 and February 17, 2025.

Remarks:

Exhibit 24 - Power of Attorney is attached.

	/s/ Angela Hatseras, Attorney-In-Fact	07/26/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.